Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Investcafe
$23.00
Provider: Investcafe
$23.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Aptechnaya set' 36,6 OAO Sells 52% of Verofarm OAO-Interfax


Thursday, 29 Aug 2013 05:57am EDT 

Interfax reported that Aptechnaya set' 36,6 OAO (Pharmacy Chain 36.6) has sold 52% of the stock in Verofarm OAO (VeroPharm) to organizations associated with businessman Mr. Roman Avdeyev for RUB 5 billion. Judging from VeroPharm's current capitalization on the Moscow Exchange, the value of the stake is an estimated RUB 4.26 billion. The buyer is GardenHills LLC, which Mr. Avdeyev controls. Russia's Federal Anti-monopoly Service (FAS) approved the buy. The other 48% of VeroPharm is in free circulation. 

Company Quote

1070.0
 --
18 Dec 2014